The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class non-opioid analgesic to treat acute pain in adults. To ...

Among the topics discussed is a deeper dive into our coverage of a surge in black-owned businesses from WHTM’s Valerie Pritchett, WFLA’s Deanne King delving into stories of everyday ...